Spero Therapeutics Statistics
NASDAQ: SPROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.16-0.01 (-0.85%)
Market open · Delayed 15 min · as of Oct 8, 11:04 AM ET
Spero Therapeutics by the numbers
Spero Therapeutics has a market capitalization of $67.6 million based on 58.23M shares outstanding. Its trailing P/E ratio is 8.3. The stock trades 3.5% below its 50-day average and 44.5% below its 200-day average.
Average daily trading volume is 1.20M shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SPRO valuation vs. peer median
| Metric | SPRO | Peer median | Difference |
|---|---|---|---|
| Market cap | $67.55M | $69.18M | -2% |
| Avg. volume | 1.20M | 502.70K | +138% |
Peer median across 8 companies: TENX, HRTX, NMAD, FBIO, MAIA, HYFT, CING, GANX.
Valuation
- Market cap
- $67.55M
- P/E (TTM)
- 8.29
- EPS (TTM)
- $0.14
- Shares outstanding
- 58.23M
Price and trading
- Previous close
- 1.17
- Open
- 1.20
- Day range
- 1.16 – 1.22
- 52-week range
- 1.08 – 3.08
- 52-week change
- -45.83%
- Beta
- —
- Volume
- 242.58K
- Average volume
- 1.20M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 67.55M
- Pe
- 8.29
- Forward Pe
- -1.05
- Eps
- 0.14
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.08
- Week52 Low
- 1.08
- Avg Volume
- 1.20M
- Shares Outstanding
- 58.23M
- Ma50
- 1.20
- Ma200
- 2.09
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -62.34%
- Pct From52w Low
- 7.41%